Rate of phenytoin accumulation in man: a simulation study.

Suppr

超能文献

作者信息

Ludden T M, Allen J P, Schneider L W, Stavchansky S A

出版信息

J Pharmacokinet Biopharm. 1978 Oct;6(5):399-415. doi: 10.1007/BF01062722.

DOI:10.1007/BF01062722

PMID:731408

Abstract

摘要

相似文献

Rate of phenytoin accumulation in man: a simulation study.

J Pharmacokinet Biopharm. 1978 Oct;6(5):399-415. doi: 10.1007/BF01062722.

Evaluation of a nomogram for estimating the rate of phenytoin accumulation.用于估计苯妥英钠蓄积率的列线图评估

Ther Drug Monit. 1987 Jun;9(2):166-70. doi: 10.1097/00007691-198706000-00007.

The effects of sucralfate upon phenytoin absorption in man.硫糖铝对人体苯妥英吸收的影响。

Br J Clin Pharmacol. 1985 Sep;20(3):238-40. doi: 10.1111/j.1365-2125.1985.tb05067.x.

Influence of food on the absorption of phenytoin in man.食物对人体苯妥英吸收的影响。

Eur J Clin Pharmacol. 1979 May 21;15(4):269-74. doi: 10.1007/BF00618516.

Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.苯妥英钠肌内注射的生物利用度及单剂量药代动力学

Clin Pharmacol Ther. 1975 Oct;18(4):449-56. doi: 10.1002/cpt1975184449.

Age and phenytoin kinetics in adult epileptics.

Clin Pharmacol Ther. 1982 Mar;31(3):301-4. doi: 10.1038/clpt.1982.37.

Interindividual variation in the extent and rate of phenytoin accumulation.

Ther Drug Monit. 1987 Jun;9(2):171-6. doi: 10.1097/00007691-198706000-00008.

Opposite effects of carbohydrate and protein on phenytoin absorption in man.碳水化合物和蛋白质对人体苯妥英钠吸收的相反作用。

Drug Nutr Interact. 1983;2(2):139-44.

The elimination of phenytoin in man.苯妥英在人体中的消除。

Clin Exp Pharmacol Physiol. 1976 May-Jun;3(3):217-24. doi: 10.1111/j.1440-1681.1976.tb02667.x.

Influence of dietary protein and carbohydrate on phenytoin metabolism in man.饮食中蛋白质和碳水化合物对人体苯妥英代谢的影响。

Br J Clin Pharmacol. 1979 Oct;8(4):369-71. doi: 10.1111/j.1365-2125.1979.tb04721.x.

引用本文的文献

Nomographic estimation of time to reach steady-state serum concentration during phenytoin therapy.

Eur J Clin Pharmacol. 1980 Jan;17(1):33-5. doi: 10.1007/BF00561674.

Rapid and slow release phenytoin in epileptic patients at steady state: comparative plasma levels and toxicity.

J Pharmacokinet Biopharm. 1982 Aug;10(4):365-82. doi: 10.1007/BF01065169.

Therapeutic drug monitoring of phenytoin. Rationale and current status.苯妥英钠的治疗药物监测。基本原理与现状。

Clin Pharmacokinet. 1990 Nov;19(5):341-58. doi: 10.2165/00003088-199019050-00001.

Nonlinear pharmacokinetics: clinical Implications.非线性药代动力学：临床意义。

Clin Pharmacokinet. 1991 Jun;20(6):429-46. doi: 10.2165/00003088-199120060-00001.

Steady-state plasma concentrations as a function of the absorption rate and dosing interval for drugs exhibiting concentration-dependent clearance: consequences for phenytoin therapy.

J Pharmacokinet Biopharm. 1979 Dec;7(6):543-55. doi: 10.1007/BF01061208.

本文引用的文献

Phenytoin dose adjustment in epileptic patients.癫痫患者的苯妥英钠剂量调整。

Br J Clin Pharmacol. 1974 Apr;1(2):163-8. doi: 10.1111/j.1365-2125.1974.tb00226.x.

A study of the pharmacokinetics of phenytoin (diphenylhydantoin) in epileptic patients, and the development of a nomogram for making dose increments.苯妥英钠（二苯乙内酰脲）在癫痫患者中的药代动力学研究及用于剂量递增的列线图的制定。

Epilepsia. 1975 Nov;16(4):627-46. doi: 10.1111/j.1528-1157.1975.tb04745.x.

Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.静脉注射后苯妥英在正常人体中的代谢情况。

Clin Pharmacol Ther. 1969 Jul-Aug;10(4):498-504. doi: 10.1002/cpt1969104498.

Diphenylhydantoin metabolism in uremia.尿毒症患者中苯妥英的代谢

N Engl J Med. 1971 Sep 16;285(12):648-52. doi: 10.1056/NEJM197109162851202.

The rate of decline of diphenylhydantoin in human plasma.人体血浆中苯妥英的下降速率。

Clin Pharmacol Ther. 1970 Jan-Feb;11(1):121-34. doi: 10.1002/cpt1970111121.

Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.通过拟合米氏方程的积分形式来解释苯妥英血浆水平的剂量依赖性下降。

Res Commun Chem Pathol Pharmacol. 1972 May;3(3):455-66.

The renal handling of diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin.苯妥英钠和5-（对羟基苯基）-5-苯基乙内酰脲的肾脏处理

Clin Pharmacol Ther. 1973 Sep-Oct;14(5):791-6. doi: 10.1002/cpt1973145791.

Acute intoxication with 5,5-diphenylhydantoin (Dilantin) associated with impairment of biotransformation. Plasma levels and urinary metabolites; and studies in healthy volunteers.5,5-二苯基乙内酰脲（苯妥英）急性中毒与生物转化受损相关。血浆水平和尿代谢产物；以及在健康志愿者中的研究。

Ann Intern Med. 1972 Nov;77(5):765-71. doi: 10.7326/0003-4819-77-5-765.

Pharmacokinetic study of a patient with diphenylhydantoin toxicity.苯妥英钠中毒患者的药代动力学研究。

Clin Pharmacol Ther. 1973 Jul-Aug;14(4):521-8. doi: 10.1002/cpt1973144part1521.

Bioavailability of four brands of phenytoin tablets.

Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):213-8. doi: 10.1007/BF00614020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验